The Hain Celestial Group Stock News

Hain Celestial (HAIN) reports soft results for first-quarter fiscal 2023. However, HAIN's North America segment's revenues increase 9% year over year in the reported quarter.

The Hain Celestial Group, Inc. (NASDAQ:HAIN ) Q1 2023 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Chris Mandeville - Managing Director-Investor Relations, ICR Mark Schill

Hain Celestial (HAIN) delivered earnings and revenue surprises of 0% and 1.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Hain Celestial's (HAIN) first-quarter fiscal 2023 earnings might have been hurt by increased costs, inflation and supply-chain disruptions.

Consumer defensive stocks have outperformed this year. These two still look undervalued to us.

LAKE SUCCESS, N.Y., Oct. 25, 2022 (GLOBE NEWSWIRE) -- The Hain Celestial Group, Inc. (Nasdaq: HAIN) (“Hain Celestial” or the “Company”), a leading organic and natural products company with ope

Hain Celestial Group (NASDAQ:HAIN) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 1 0 0

Over the past 3 months, 5 analysts have published their opinion on Hain Celestial Group (NASDAQ:HAIN) stock. These analysts are typically employed by large Wall Street banks and tasked with understand

Wells Fargo lowered the price target for Adobe Inc. (NASDAQ: ADBE) from $425 to $310. Adobe shares fell 1.2% to $296.04 in pre-market trading. Mizuho boosted the price target on AvalonBay Communiti

LAKE SUCCESS, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) -- The Hain Celestial Group, Inc. (Nasdaq: HAIN) (“Hain Celestial”, “Hain” or the “Company”), a leading organic and natural products c

While few enjoy the pain of red ink in the markets when volatility strikes, forward-thinking investors can use the current circumstances to load up on intriguing stocks to buy. To be sure, fear has on

Upgrades According to Argus Research, the prior rating for AstraZeneca PLC (NASDAQ:AZN) was changed from Hold to Buy. For the second quarter, AstraZeneca had an EPS of $0.86, compared to year-ago quar

U.S. stocks closed sharply lower with the Dow Jones tumbling more than 1,000 points on Friday. Here is the list of some big stocks moving lower in the previous session. Domo, Inc. (NASDAQ: DOMO) shar

Gainers Micro Focus International plc (NYSE: MFGP) shares surged 92% to close at $6.01 on Friday after the company reached an agreement with OpenText to be acquired for $6 billion. Minerva Neuroscien

Hain Celestial (HAIN) reports soft results for fourth-quarter fiscal 2022. Several challenges, mainly in Europe, and unfavorable foreign currency translations hurt results.